Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Abela

Showing results (61-70 of 63) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 63 results.
Open Forum Infectious Diseases|November 29, 2023
Antibody Response After the Third SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients and People Living With HIV (COVERALL-2)Alexandra Griessbach, Frédérique Chammartin, Irene A Abela, et al.
The Journal of Infectious Diseases|June 7, 2024
Antibody and T-Cell Response to Bivalent Booster SARS-CoV-2 Vaccines in People With Compromised Immune Function: COVERALL-3 StudyAlain Amstutz, Frédérique Chammartin, Annette Audigé, et al.
Nature Communications|November 19, 2021
Multifactorial seroprofiling dissects the contribution of pre-existing human coronaviruses responses to SARS-CoV-2 immunityIrene A Abela, Chloé Pasin, Magdalena Schwarzmüller, et al.
Pageof 7

Showing results (61-70 of 63) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 63 results.
Open Forum Infectious Diseases|November 29, 2023
Antibody Response After the Third SARS-CoV-2 Vaccine in Solid Organ Transplant Recipients and People Living With HIV (COVERALL-2)Alexandra Griessbach, Frédérique Chammartin, Irene A Abela, et al.
The Journal of Infectious Diseases|June 7, 2024
Antibody and T-Cell Response to Bivalent Booster SARS-CoV-2 Vaccines in People With Compromised Immune Function: COVERALL-3 StudyAlain Amstutz, Frédérique Chammartin, Annette Audigé, et al.
Nature Communications|November 19, 2021
Multifactorial seroprofiling dissects the contribution of pre-existing human coronaviruses responses to SARS-CoV-2 immunityIrene A Abela, Chloé Pasin, Magdalena Schwarzmüller, et al.
Pageof 7